APalutamiAPalutamide and stEReotactic Body Radiation Therapy for Metastatic Prostate Cancer

Clinical trial NCT05717660 · UNKNOWN

Trial details

NCT number: NCT05717660
Sponsor: Azienda Ospedaliero-Universitaria Careggi
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Oligometastatic Hormone Sensitive Prostate Cancer

Start date: 2023-03-11
Primary completion: 2024-09-11
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.